30 November 2011 14:30 [Source: ICIS news]
HOUSTON (ICIS)--?xml:namespace>
Verdezyne said its project, at
“This is the first demonstration of the production of bio-based adipic acid at scale from a non-petroleum source,” said William Radany, Verdezyne’s CEO.
“Our novel yeast platform enables production of adipic acid at a lower cost than current petrochemical manufacturing processes,” Radany added.
Capacity and financial terms were not disclosed.
In addition to Verdezyne, other US-based renewable chemical firms such as Rennovia and BioAmber are looking at developing bio-based adipic acid.
Privately-held Verdezyne is focused on developing yeast strains for cost-effective production of bio-based chemicals and fuels.
Its investors include BP Alternative Energy Ventures and DSM Venturing, among others.
For more on ADA visit ICIS Chemical Intelligence
Check out Doris de Guzman’s Green Chemicals Blog for views on sustainability issues
For the latest chemical news, data and analysis that directly impacts your business sign up for a free trial to ICIS news - the breaking online news service for the global chemical industry.
Get the facts and analysis behind the headlines from our market leading weekly magazine: sign up to a free trial to ICIS Chemical Business.
| ICIS news FREE TRIAL |
| Get access to breaking chemical news as it happens. |
| ICIS Global Petrochemical Index (IPEX) |
| ICIS Global Petrochemical Index (IPEX). Download the free tabular data and a chart of the historical index |